Compounds > 5-(3-methyl-1-triazeno)imidazole-4-carboxamide
Page last updated: 2024-08-25

5-(3-methyl-1-triazeno)imidazole-4-carboxamide and nad

5-(3-methyl-1-triazeno)imidazole-4-carboxamide has been researched along with nad in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harris, AL; Lunn, JM1

Other Studies

1 other study(ies) available for 5-(3-methyl-1-triazeno)imidazole-4-carboxamide and nad

ArticleYear
Cytotoxicity of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (MTIC) on Mer+, Mer+Rem- and Mer- cell lines: differential potentiation by 3-acetamidobenzamide.
    British journal of cancer, 1988, Volume: 57, Issue:1

    Topics: Alkylating Agents; Benzamides; Cell Survival; Dacarbazine; DNA Damage; Dose-Response Relationship, Drug; Drug Synergism; Humans; Mitosis; NAD; Nucleotidyltransferases; Tumor Cells, Cultured

1988